Pattern of drug use by advanced cancer patients followed at home

Journal of Palliative Care

Volumn 17, Issue 1, 2001, Pages 37-40

  Mercadante, Sebastiano ^a   Fulfaro, Fabio ^a   Casuccio, Alessandra ^b  

^a SAMOT Onlus   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CLINICAL PRACTICE; DRUG MONITORING; DRUG UTILIZATION; EVIDENCE BASED MEDICINE; FEMALE; HOME CARE; HUMAN; MALE; MEDICAL AUDIT; MORTALITY; NEOPLASM; PRACTICE GUIDELINE; PRESCRIPTION; RETROSPECTIVE STUDY; STANDARD; STATISTICS; SURVIVAL; TERMINAL CARE;

AGED; DRUG MONITORING; DRUG UTILIZATION; EVIDENCE-BASED MEDICINE; FEMALE; HOME CARE SERVICES; HUMANS; MALE; MEDICAL AUDIT; NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TERMINAL CARE;

EID: 0035287157     PISSN: 08258597     EISSN: None     Source Type: Journal    
DOI: 10.1177/082585970101700106     Document Type: Article

References (15)

1. Curtis EB, Walsh D. Prescribing practices of a palliative care service. J Pain Symptom Manage 1993; 8: 312-316.
2. Twycross RG, Bergl S, Sally J, Lewis K. Monitoring drug use in palliative care. Palliat Med 1994; 8: 137-143.
3. Mercadante S. Pain treatment and outcomes for patients with advanced cancer who receive follow-up care at home. Cancer 1999; 85: 1849-1858.
4. Mercadante S. Similar pain in different countries. J Pain Symptom Manage 1996; 12: 270-271.
5. Zech DFJ, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain 1995; 63: 65-76.
6. Raskin JB, White RH, Jaszewski R, Korsten MA, Schubert TT, Fort JG. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study. Am J Gastroenterol 1996; 91: 223-227.
7. Yeomans ND, Tulassay ZT, Juhasz L, Racz I, Howard JM, Van Rensburg CJ, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. N Eng J Med 1998; 338: 719-726.
8. Bruera E, Navigante A, Barugel M, Macmillan K, MacDonald RN, Chacon R. Treatment of pain and other symptoms in cancer patients: patterns in a North American and a Southern American hospital. J Pain Symptom Manage 1990; 5: 78-82.
9. Hoskins PJ, Hanks GW. The management of symptoms in advanced cancer, experience in a hospital-based continuing care unit. J R Soc Med 1988; 81: 341-344.
10. Donnelly S, Walsh D, Rybicki L. The symptoms of advanced cancer: identification of clinical and research priorities by assessment of prevalence and severity. J Palliat Care 1995; 11: 27-32.
11. Grond S, Zech D, Diefenbach C, Bischoff A. Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic. J Pain Symptom Manage 1994; 9: 372-382.
12. Mercadante S, Casuccio A, Pumo S, Fulfaro F. Factors influencing the opioid response in advanced cancer patients with pain followed at home: the effects of age and gender. Support Care Cancer 2000; 8: 123-150.
13. Mercadante S, Casuccio A, Pumo S, Fulfaro F. Opioid responsiveness-primary diagnosis relationship in advanced cancer patients followed at home. J Pain Symptom Manage 2000; 20: 112-120.
14. Bruera E, Fainsinger L, Schoeller T, Ripamonti C. Rapid discontinuation of hypnotics in terminal cancer patients. Ann Oncol 1996; 7: 855-856.
15. Mercadante S, Fulfaro F, Casuccio A. The impact of home palliative care on symptoms in advanced cancer patients. Support Care Cancer 2000; 8: 307-310.